Kintor Pharmaceutical Ltd - ESG Rating & Company Profile powered by AI
Other companies in the rating peer group for Kintor Pharmaceutical Ltd are displayed below. This Disclosure score covers seventeen UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Reduced Inequalities' and 'Life below Water'. If you work at Kintor Pharmaceutical Ltd and you would like to use your ESG rating, please get in touch.
Kintor Pharmaceutical Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.1; made up of an environmental score of 2.7, social score of 2.3 and governance score of 1.3.
2.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1551 | Voyager Life PLC | 2.2 | Medium |
| 1551 | Source Natural Foods and Herbal Supplements Ltd | 2.2 | Medium |
| 1571 | Kintor Pharmaceutical Ltd | 2.1 | Medium |
| 1571 | Cerevel Therapeutics Holdings Inc | 2.1 | Medium |
| 1571 | Charlotte's Web Holdings Inc | 2.1 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Kintor Pharmaceutical Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd report the average age of the workforce?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd offer flexible work?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd conduct supply chain audits?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose water use targets?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Kintor Pharmaceutical Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Kintor Pharmaceutical Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Kintor Pharmaceutical Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose its waste policy?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose energy use targets?
Sign up for free to unlockDoes Kintor Pharmaceutical Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Kintor Pharmaceutical Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Kintor Pharmaceutical Ltd
These potential risks are based on the size, segment and geographies of the company.
Kintor Pharmaceutical Limited, a biopharmaceutical company, engages in the research and development of drugs for the treatment of various cancers and other androgen receptor (AR) - related diseases in China, the United States, and Taiwan. The company's lead drug candidates include Proxalutamide, a small molecule second generation AR antagonist that is in various clinical trials for metastatic castration-resistant prostate cancer and breast cancer, as well as for the treatment of COVID-19; and Pyrilutamide, which is in various clinical trials for androgenetic alopecia and acne vulgaris. It also develops ALK-1 for the treatment of metastatic hepatocellular carcinoma and liver cancer; Detorsertib, a second-generation mTOR inhibitor for the treatment of metastatic solid tumours; GT1708F for the treatment of leukaemia and basal-cell carcinoma; and GT20029 for the treatment of androgenetic alopecia and acne vulgaris. The company was founded in 2009 and is headquartered in Suzhou, China.